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Ciprofloxacinium malonate dihydrate (I), C17H19FN3O3+∙C3H3O4−∙H2O, (C17H18FN3O3 – ciprofloxacin, 
CfH; C3H4O4 − malonic acid) has been crystallized from the mutual solution of malonic acid and 
ciprofloxacin in ambient conditions. It has improved aqueous solubility against the ciprofloxacin. 
The colourless crystals have been investigated using X-ray single crystal and powder techniques, 
and characterized by differential scanning calorimetry and thermogravimetry. The obtained 
compound can be considered as a salt with ciprofloxacinium in the role of a cation and malonate 
as an anion. The compound is crystallized in the triclinic lattice with a = 7.283(2), b = 10.090(3), 
c = 15.104(5)Å, α = 102.711(4), β = 103.328(4), γ = 94.261(4)°, Z = 2, V = 1044.5(6)Å3, S.G. P1 . The 
crystal structure determination reveals the importance of inter- and intramolecular interactions in 
the crystal formation. Thermal behavior and solubility of I provided complementary evidences of 
salt formation.
Keywords: ciprofloxacinium malonate dihydrate, crystal structure, thermal behavior.
Ciprofloxacin (CfH), 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic 
acid, is a fluoroquinolone antibiotic approved for the treatment of several types of infections [1]. 
In aqueous solutions CfH exists mainly in its zwitterionic form, due to the acid base interaction 
between the piperazine basic nitrogen and the carboxylic group. As a consequence the aqueous 
solubility of CfH at pHs close to 7 (isoelectric point of the molecule) is low (0.088 mg/ml) [2]. This 
property makes it difficult to formulate optimized liquid dosage forms such as parenteral, ototopic 
or ophthalmic solutions. Moreover, ciprofloxacin is characterized by a bitter taste [3], which is an 
additional complication for the oral administration of it. It has been proposed that CfH bioavailability 
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can be limited by both solubility and permeability [4]. For active pharmaceutical ingredients (APIs) 
with solubility-limited bioavailability, a challenging task in the development of the product is to 
improve their solubility without compromising other performance. Indeed, a widely accepted 
approach to overcome poor solubility of an API is the preparation of their salt forms [5]. Organic 
salts are generally the preferred crystal form of active pharmaceutical ingredients because of their 
higher solubility and/or increased degree of crystallinity. Crystalline APIs are strongly preferred 
due to their relative ease of isolation, the rejection of impurities inherent to the crystallization 
process and the physicochemical stability that the crystalline solid state affords. The malonic acid 
is one of active pharmaceutical ingredients [6], and it can be used for preparation soluble forms 
fluoroquinolone [7]. 
The aim of this work is to present a new compound CfH2Mal (Mal− = C3H3O4−, anion of malonic 
acid) with improved degree of crystallinity and aqueous solubility.
Experimental
CfH was obtained from the hydrochloride salt (ciprofloxacin hydrochloride monohydrate, 
CfH·HCl·H2O, Ranbaxia, India, pharmaceutical grade). Ciprofloxacin hydrochloride monohydrate 
was dissolved in the solution of concentrated ammonia. Then few drops of 4 M HCl were added 
(pH 8) and white microcrystals of anhydrous ciprofloxacin have precipitated. For the preparation of 
ciprofloxacinium malonate dihydrate (I), a mixture of anhydrous ciprofloxacin (0.20 g, 0.60 mmol) 
and malonic acid (0.065 g, 0.63 mmol) in water (5 ml) was dissolved. The solution has been kept in a 
fume hood and colorless crystals have grown in several days. These crystals were used to determine 
the crystal structure of the compound by X-ray diffraction and to carry on the analysis through the 
other techniques.
The TG and DSC (Fig. 1) curves show mass losses at least in four steps for I. The first mass loss 
between 80 and 170ºC corresponds to an endothermic peak (DSC) and the extremum (DTG) at 90ºC 
is due to dehydration. Estimated (6.37 %) and calculated (7.64 %) mass losses for two water molecule 
 
Fig. 1. TG and DSC curves for ciprofloxacinium malonate dihydrate 
 
The solubility of I at 298 K was estimated in distilled water using the shake-flask method over 
24 h. The concentration of the compound in the filtrate was quantified using UV spectroscopy 
[10]. The solubility of I at 298 K is equal 0.024 M (pH 5.5) that higher than of the corresponding 
ciprofloxacin [2]. Also, the pH of the malonate solutions is higher than used in pharmacology of 
the corresponding hydrochloride.  
So, the thermal behavior and solubility of I provided complementary evidences of salt 
formation. The product showed improved properties with respect to water solubility and 
increased degree of crystallinity. This salt would be a good way forward to developing more 
suitable formulation of this APIs. 
Single crystal X-ray diffraction data were collected with MoKα radiation on a Bruker 
SMART APEX II CCD diffractometer using a crystal sample of dimensions 0.381×0.316×0.260 
mm. Experimental absorption corrections were performed using the multi-scan method and the 
program SADABS [11]. Structure was solved by direct methods using the program complex 
SHELXS [12] and was refined with the program complex SHELXL [12]. The asymmetric unit of 
the crystal cell contains ions of CfH2+, C3H3O4− one by one and two molecules of water. All H 
atoms were subsequently located on difference electron density maps and then refined in 
idealized positions with constrained mode. The main crystallographic data and refinement 
parameters are gathered in Table 1. 
 Due to the presence of NH2 group in CfH2+, oxygen atoms in CfH2+ and in C3H3O4− as 
well as H2O molecules  in the structure arose  a net of intermolecular H-bonds of N–H⋅⋅⋅O and 
O–H⋅⋅⋅O type which don’t involve O3 and O5 atoms only (Fig. 2 and 3). The H-bond paramers 
are presented in Table 2. The main features of the bonds are centrosymmetric cycles of four 
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are in fair agreement. The anhydrous compound is stable up to 190 °С and between 190 and 230 °С the 
thermal decomposition occurs in a single step. In this step the DSC curve shows a strong endothermic 
peak at 210 °С. The mass loss (estimated 21.82 % and calculated 22.07 %) corresponds to the lost of 
malonic acid molecule. The thermal decomposition of this acid occurs with decarboxylation followed 
by the formation of acetic acid [8]. The constant mass of the substance in temperature range 220-290 °С 
is received. The third endothermic peak at 278 °С is attributed to the melting of formed ciprofloxacin 
and its position coincidents with the melting point of ciprofloxacin (277 °С) [9]. Estimated (28.2 %) 
and calculated (29.7 %) mass losses in this step are in good agreement. The pyrolysis of CfH starts 
at 290 °С with simultaneous evolution of water and carbon dioxide [9]. The process is not finished at 
900  °С (the mass loss is equal to 93 %, Fig. 1). 
The solubility of I at 298 K was estimated in distilled water using the shake-flask method over 24 
h. The concentration of the compound in the filtrate was quantified using UV spectroscopy [10]. The 
solubility of I at 298 K is equal 0.024 M (pH 5.5) that higher than of the corresponding ciprofloxacin 
[2]. Also, the pH of the malonate solutions is higher than used in pharmacology of the corresponding 
hydrochloride. 
So, the thermal behavior and solubility of I provided complementary evidences of salt formation. 
The product showed improved properties with respect to water solubility and increased degree of 
crystallinity. This salt would be a good way forward to developing more suitable formulation of this 
APIs.
Single crystal X-ray diffraction data were collected with MoKα radiation on a Bruker SMART 
APEX II CCD diffractometer using a crystal sample of dimensions 0.381×0.316×0.260 mm. 
Experimental absorption corrections were performed using the multi-scan method and the program 
SADABS [11]. Structure was solved by direct methods using the program complex SHELXS [12] 
and was refined with the program complex SHELXL [12]. The asymmetric unit of the crystal 
cell contains ions of CfH2+, C3H3O4− one by one and two molecules of water. All H atoms were 
subsequently located on difference electron density maps and then refined in idealized positions 
with constrained mode. The main crystallographic data and refinement parameters are gathered in 
Table 1.
Due to the presence of NH2 group in CfH2+, oxygen atoms in CfH2+ and in C3H3O4− as well as 
H2O molecules  in the structure arose  a net of intermolecular H-bonds of N–H…O and O–H…O 
type which don’t involve O3 and O5 atoms only (Fig. 2 and 3). The H-bond paramers are presented in 
Table 2. The main features of the bonds are centrosymmetric cycles of four water molecules (Fig. 3). 
Molecules of the cycle are hydrogen bonded with each other and also involved in the same bonds 
with four C3H3O4− ions and two CfH2+ ions. As a result the Ow1 atom is twice hydrogen-bond donor 
and twice hydrogen-bond acceptor whereas the Ow2 atom is twice hydrogen-bond donor and once 
hydrogen-bond acceptor.
CfH2+ ions are packed up in infinite stacks along the crystallographic a-axis (Fig. 4) in the crystal. 
Each stack consists of molecules united in pairs by inversion centers with [n; 1/2; 1/2] coordinates, 
where n is integer, and the pairs are fastened by two additional C12–H8…О1 H-bonds (Table 2). The 
pairs are connected with each other by inversion centers with [n+1/2; 1/2; 1/2] coordinates. As a result, 
additional supramolecular interactions present at the stack between π-conjugated orbitals of plane 
molecular cycles; their parameters are shown in Table 3.
Table 1. Experimental details and refinement parameters for CfH2Mal ×2H2O
Chemical formula moiety C17H19N3O3F×C3H3O4×2H2O
Temperature (K) 298
Space group P1 
Z 2
2θmax, (°) 52
a, b, c  (Å); 7.283(2);  10.090(3);  15.104(5)
α;  β;  γ (°) 102.711(4);  103.328(4);  94.261(4)
V, Å3 1044.5(6)
d, (g/cm3) 1.499
μ, (mm-1) 0.124
Reflections measured 8386
Reflections independent 4076
Reflections with F>4σF 2508
Rint / Rσ 0,030 / 0,049
h, k, l – limits –8 ≤ h ≤ 8; –12 ≤ k ≤ 12; –18 ≤ l ≤ 18
Refinement results
Refinement on F2 w = 1/[σ
2(Fo2)+(0,0617P)2+0,06P];
P = (Fo2+2Fc2)/3
Refinement parameters 320
R1 [Fo > 4σ(Fo)] 0.0478
wR2 0.1371
Extinction coefficient 0.012(2)
GooF 1.04
(∆ρ)max, e/Å3 0.215
(∆ρ)min, e/Å3 –0.224
(∆/σ)max 0.000
Ow1–Hw12 0.90(1) 1.99(1) 161(3) 2.853(3) O7 x, y, z 
Ow2–Hw21 0.90(1) 1.86(1) 171(3) 2.745(3) O6 1+x, y, z 
Ow2–Hw22 0.90(1) 2.04(1) 154(2) 2.875(3) Ow1 x, y, z 
C14–H13 0.97 2.13 129 2.846(3) F x, y, z 
C12–H8 0.97 2.24 170 3.202(3) O1 –x, 1–y, 1–z 
  
Table 3. Parameters* of π–π-interactions between (cfH2)+ ions in the structure 
Cgi–Cgj 
symmetrical 
transformation 
of ring j 
d (Å) α (°). β (°). Cgi_p (Å) Cgj_p (Å) Slip (Å) 
Cg1–Cg1 
Cg1–Cg2 
Cg1–Cg2 
Cg2–Cg1 
Cg2–Cg1 
Cg2–Cg2 
–x,1–y,1–z 
–x,1–y,1–z 
1–x,1–y,1–z 
–x,1–y,1–z 
1–x,1–y,1–z 
1–x,1–y,1–z 
3.821(2) 
3.796(2) 
3.618(2) 
3.796(2) 
3.618(2) 
3.680(2) 
– 
2.7(1) 
2.7(1) 
2.7(1) 
2.7(1) 
– 
23.4 
20.2 
19.9 
22.2 
22.5 
22.5 
3.5056(9) 
3.5154(9) 
3.3435(9) 
3.5572(9) 
3.4030(9) 
3.3996(9) 
3.5057(9) 
3.5572(9) 
3.4030(9) 
3.5154(9) 
3.3435(9) 
3.3996(9) 
1.52 
– 
– 
– 
– 
1.41 
 
* d – distance between ring centroids; α – dihedral angle between planes i and j; β – angle 
between Cgi→Cgj vector and normal to plane i; Cgi_p – perpendicular distance of Cgi on ring j; 
Cgj_p – perpendicular distance of Cgj on ring i; Slip – distance between Cgi and perpendicular 
projection of Cgj on ring i. Сg1: N1-C2-C3-C4-C10-C9;   Сg2: С5-С6-С7-С8-С9-С10. 
 
 
 
Fig. 2. The structure of C17H19N3O3F+ and C3H3O4− with atom numbering scheme. The 
intramolecular H-bonds are shown as dotted lines 
 
Table 2. Selected bond distances (Å) and angles (°) 
 
Fig. 2. The structure of C17H19N3O3F+ and C3H3O4− with 
atom numbering scheme. The intramolecular H-bonds 
are shown as dotted lines
Fig. 3. H-bonds (dotted lines) with the participation of 
CfH2+ and Mal−
bond d bond d 
O1–С4 1.263(3) O6–С20 1.252(3) 
O2–C1 1.324(3) O7–С20 1.243(3) 
O3–C1 1.203(3) C19–C18 1.493(3) 
O4–С18 1.304(3) C19–C20 1.496(3) 
O5–С18 1.205(3)   
angle ω angle ω 
O1–C4–C3 122.5(2) O4–C18–O5 120.8(2) 
O2–C1–C3 115.8(2) O4–C18–C19 121.9(3) 
O3–C1–C3 123.6(2) C18–C19–C20 119.7(2) 
O2–C1–O3 20.6(2) O6–C20–C19 117.5(2) 
  O6–C20–O7 124.7(2) 
 
 
Fig. 3. H-bonds (dotted lin s) with the participation of CfH2+ and Mal− 
 
 
Fig. 4. H-bonds (dotted lines) of water molecules. There shown N3 atom with its environment 
only instead of CfH2+ ion, for clarity 
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Fig. 4. H-bonds (dotted lines) of water molecules. There shown 
N3 atom with its environment only instead of CfH2+ ion, for 
clarity
Table 2. Geometrical parameters of H-bonds, D–H⋅⋅⋅A, and short contacts in the structure. Bond lengths (Å) and 
angles (°)
D–H d(D–H) d(H⋅⋅⋅A) ∠DHA d(D⋅⋅⋅A) A transformation
for А-atom (acceptor)
O2–H1 0.91(1) 1.65(1) 161(3) 2.531(2) O1 x, y, z
N3–H2 0.90 1.89 158 2.746(3) O7 1+x, 1+y, 1+z
N3–H3 0.90 2.00 166 2.880(3) Ow1 x, 1+y, 1+z
O4–H20 0.91(1) 1.62(2) 159(3) 2.489(3) O6 x, y, z
Ow1–Hw11 0.90(1) 1.88(1) 168(2) 2.757(3) Ow2 1–x, –y, –z
Ow1–Hw12 0.90(1) 1.99(1) 161(3) 2.853(3) O7 x, y, z
Ow2–Hw21 0.90(1) 1.86(1) 171(3) 2.745(3) O6 1+x, y, z
Ow2–Hw22 0.90(1) 2.04(1) 154(2) 2.875(3) Ow1 x, y, z
C14–H13 0.97 2.13 129 2.846(3) F x, y, z
C12–H8 0.97 2.24 170 3.202(3) O1 –x, 1–y, 1–z
Table 3. Parameters* of π–π-interactions between (cfH2)+ ions in the structure
Cgi–Cgj
Symmetrical 
transformation 
of ring j
d (Å) α (°). β (°). Cgi_p (Å) Cgj_p (Å) Slip (Å)
Cg1–Cg1
Cg1–Cg2
Cg1–Cg2
Cg2–Cg1
Cg2–Cg1
Cg2–Cg2
–x,1–y,1–z
–x,1–y,1–z
1–x,1–y,1–z
–x,1–y,1–z
1–x,1–y,1–z
1–x,1–y,1–z
3.821(2)
3.796(2)
3.618(2)
3.796(2)
3.618(2)
3.680(2)
–
2.7(1)
2.7(1)
2.7(1)
2.7(1)
–
23.4
20.2
19.9
22.2
22.5
22.5
3.5056(9)
3.5154(9)
3.3435(9)
3.5572(9)
3.4030(9)
3.3996(9)
3.5057(9)
3.5572(9)
3.4030(9)
3.5154(9)
3.3435(9)
3.3996(9)
1.52
–
–
–
–
1.41
* d – distance between ring centroids; α – dihedral angle between planes i and j; β – angle between Cgi→Cgj vector and normal 
to plane i; Cgi_p – perpendicular distance of Cgi on ring j; Cgj_p – perpendicular distance of Cgj on ring i; Slip – distance 
between Cgi and perpendicular projection of Cgj on ring i. Сg1: N1-C2-C3-C4-C10-C9;   Сg2: С5-С6-С7-С8-С9-С10.
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Table 2. Selected bond distances (Å) and angles (°)
bond d bond d
O1–С4 1.263(3) O6–С20 1.252(3)
O2–C1 1.324(3) O7–С20 1.243(3)
O3–C1 1.203(3) C19–C18 1.493(3)
O4–С18 1.304(3) C19–C20 1.496(3)
O5–С18 1.205(3)
angle ω angle ω
O1–C4–C3 122.5(2) O4–C18–O5 120.8(2)
O2–C1–C3 115.8(2) O4–C18–C19 121.9(3)
O3–C1–C3 123.6(2) C18–C19–C20 119.7(2)
O2–C1–O3 120.6(2) O6–C20–C19 117.5(2)
O6–C20–O7 124.7(2)
 
Fig. 5. The molecular packing of the CfH2+ ions in the unit cell. Dashed lines are C12–H8⋅⋅⋅О1 
bonds 
Fig. 5. The molecular packing of the CfH2+ ions in the 
unit cell. Dashed lines are C12–H8⋅⋅⋅О1 bonds
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Дигидрат малоната ципрофлоксациниума:  
приготовление, кристаллическая структура,  
термическая устойчивость
А.Д. Васильева,б, Н.Н. Головнева
аСибирский федеральный университет, 
Россия 660041 Красноярск, пр. Свободный, 79
бИнститут физики им. Л.В. Киренского СО РАН 
Россия 660036, Красноярск, Академгородок, 50/38
Дигидрат малоната ципрофлоксациниума (I), C17H19FN3O3+∙C3H3O4−∙H2O, (C17H18FN3O3 – 
ciprofloxacin, CfH; C3H4O4 − malonic acid) выделен при взаимодействии в водном растворе 
малоновой кислоты и ципрофлоксацина при обычных условиях. Полученные бесцветные 
кристаллы исследованы и охарактеризованы методами монокристального РСА, РФА, 
дифференциальной сканирующей калориметрии и термографии. Соединение I является солью, 
состоящей из катиона ципрофлоксациниума и малонат-аниона. Оно кристаллизуется в форме 
триклинных  кристаллов с параметрами a=7.283(2), b=10.090(3), c=15.104(5)Å, α=102.711(4), 
β=103.328(4), γ=94.261(4)°, Z=2, V=1044.5(6)Å3, пр. гр. P1 . Анализ кристаллической структуры 
указывает на важность внутри- и межмолекулярных взаимодействий при образовании 
кристалла. Данные по термической устойчивости и растворимости I подтверждают 
образование соли.
Ключевые слова: дигидрат малоната ципрофлоксациниума, кристаллическая структура, 
термическая устойчивость.
